PRCT 241115 77.50C (PRCT241115C77500) Stock Options, News & Quotes

3.30
-1.54-31.82%

15min DelayClose Oct 18 15:59 ET

3.30High3.20Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo Recap US

Aug 21 15:32

Columns FOMC Members Ready to Cut Rates In Sept

The market climbed after feeling the first day of pullback in nearly two weeks the day before.
Just after 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.42%, the $Dow Jones Industrial Average (.DJI.US)$ traded +0.14%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.57%.
Investors are digesting retail earnings and the tail end of tech reports, alongside comments made during the Democratic National Committee, where the Harris campaign made public t...

Powell said it's time to cut: Will the market go wild?

Kevin Travers

Aug 21 09:56

Columns U.S. Stocks Rebound, Retail Companies Facing Inflation Woes | Moovin Stonks

Good morning, traders. Happy Wednesday. The market is advancing again after pulling back from a nearly ten day climb Tuesday. Retail earnings this morning came in mixed, the DNC is still roaring on in Chicago.
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...

Powell said it's time to cut: Will the market go wild?

Moomoo AI

Mar 11 05:30

Recent insider selling of PROCEPT BioRobotics shares and lack of insider buying, along with not particularly high insider ownership, raises caution about the company. Consider the company's investment risks before purchasing.

This Insider Has Just Sold Shares In PROCEPT BioRobotics

Moomoo AI

Feb 14 06:10

PROCEPT BioRobotics has a conservative balance sheet and could probably eliminate its debt without much difficulty. Despite losing money over the last twelve months, the company's solid revenue growth may indicate a path to profitability.

Does PROCEPT BioRobotics (NASDAQ:PRCT) Have A Healthy Balance Sheet?

Moomoo AI

Nov 17, 2023 04:30

Insider selling at PROCEPT BioRobotics' current share price levels doesn't imply major concern nor positivity. Lack of insider purchases in the past year and shares held by insiders, combined with past sales, call for careful investments due to potential company risks.

Don't Ignore The Insider Selling In PROCEPT BioRobotics